Loading PLX charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading PLX comparable companies…
| PLXProtalix BioTherapeutics, Inc.(opens in a new tab) | $0.21B | $0.08B | +30.1% | 69.2% | 28.9% | 2.65× | 11.3× |
|---|---|---|---|---|---|---|---|
| CGENCompugen Ltd(opens in a new tab) | $0.19B | $0.07B | +161.1% | 87.3% | 43.1% | 2.57× | 5.2× |
| FDMT4D Molecular Therapeutics, Inc.(opens in a new tab) | $0.83B | $0.09B | +278712.1% | — | −214.2% | 9.07× | — |
| KYMRKymera Therapeutics, Inc.(opens in a new tab) | $12.68B | $0.10B | +133.8% | 0.0% | −396.0% | 124.05× | — |
| CSBRChampions Oncology, Inc.(opens in a new tab) | — | $0.06B | +6.7% | 49.8% | −1.7% | — | — |
| Medianpeers, excl. PLX | $0.83B | $0.08B | +147.5% | 49.8% | −108.0% | 9.07× | 5.2× |